Quoc Le-Nguyen - 09 May 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Signature
/s/ Ryan A. Murr, as attorney-in-fact for Quoc Le-Nguyen
Issuer symbol
ETNB
Transactions as of
09 May 2023
Net transactions value
-$333
Form type
4
Filing time
11 May 2023, 17:01:42 UTC
Previous filing
04 Apr 2023
Next filing
05 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $189,539 +60,945 +62% $3.11* 160,028 09 May 2023 Direct
transaction ETNB Common Stock Options Exercise $57,927 +18,626 +12% $3.11* 178,654 09 May 2023 Direct
transaction ETNB Common Stock Sale $247,799 -13,683 -7.7% $18.11 164,971 09 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -60,945 -94% $0.000000 4,063 09 May 2023 Common Stock 60,945 $3.11 Direct F2
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -18,626 -85% $0.000000 3,312 09 May 2023 Common Stock 18,626 $3.11 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 3, 2023.
F2 This option represents a right to purchase a total of 65,008 shares of the Issuer's common stock and is vested in full.
F3 This option represents a right to purchase a total of 26,486 shares of the Issuer's common stock, one quarter of which vested on July 23, 2020, with the remaining three quarters vesting in equal quarterly installments over the following three years.

Remarks:

Chief Technical Operations Officer and Head of Quality